Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2023 | Quality of life with octocog alfa in patients with hemophilia A: read-out of the AHEAD study

Kate Khair • 27 Jun 2023
ISTH 2023
Hemophilia Non-Malignant Octocog alfa
AHEAD

Kate Khair, PhD, Haemnet, London, UK, briefly discusses patient quality of life (QoL) outcomes from the interim read-out of the AHEAD study, which is evaluating octocog alfa in patients with hemophilia A (NCT02078427). This study measured QoL over time, allowing for tracking of QoL alongside treatment. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kate Khair

0:56
Life with Glanzmann’s thrombasthenia: the Glanzmann’s 360 study
Kate Khair • 27 Jun 2023

Related Videos

2:46
Morbidity and mortality data from the UK National Haemoglobinopathy Registry
Farrukh Shah • 30 Apr 2024
3:47
The modeling of HbS dynamics following red cell exchange transfusion to improve patient care
Richard Salisbury • 28 Apr 2024
2:41
A trial investigating enoxaparin vs placebo as thromboprophylaxis in hospitalized older patients
Gregoire Le Gal • 29 Apr 2024
1:09
Improving the mental health and psychological resilience of patients with SCD
Marsha Treadwell • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals